Sign In
Buy ABBV
$224.93
+7.86 (+3.62%)
At Close: Jun 04, 2026
AbbVie Shares Rise To Intraday High After Key Trading Signal
03:06pm, Wednesday, 12'th Nov 2025
AbbVie Inc (NYSE:ABBV) experienced a significant Power Inflow alert, a key bullish indicator that is closely tracked by traders who value order flow analytics, specifically institutional and retail or
How Much Did Skyrizi and Rinvoq Drive AbbVie's Q3 Performance?
12:56pm, Wednesday, 12'th Nov 2025
ABBV's growth engine keeps humming as Skyrizi and Rinvoq together now power more than 40% of total revenues and drive new market share gains.
- A total of 17 abstracts, including three accepted for presentation in the Cosmetic "Top Ten" Session, underscore Allergan Aesthetics' global industry leadership across multiple aesthetic categories
PARMA, Italy, Nov. 12, 2025 (GLOBE NEWSWIRE) -- Chiesi Group today announced it has entered into an exclusive license agreement with Aliada Therapeutics, a wholly owned subsidiary of AbbVie, to advanc
AbbVie Has Many Bullish Attributes (Technical Analysis)
10:40pm, Tuesday, 11'th Nov 2025
AbbVie presents a bullish outlook supported by positive earnings, a strong dividend, and robust technical indicators. ABBV beat Q3 earnings and revenue expectations, raised full-year EPS guidance, and
Three Healthcare Buys That Wall Street Loves
10:50am, Tuesday, 11'th Nov 2025
New technologies and an aging population are lifting the healthcare sector. Immunotherapy and anti-obesity drugs are leading the way.
5 Top Stocks to Buy in November
08:49am, Tuesday, 11'th Nov 2025
As we wind down 2025, the markets are looking shaky and I want my portfolio to be well diversified in the case of a recession or market correction. As such, in today's video I am going to take all thi
What Is Considered a Good Stock Dividend? 3 Healthcare Stocks That Fit the Bill.
11:05am, Sunday, 09'th Nov 2025
Skyrizi and Rinvoq sales are pushing AbbVie's sales higher. UnitedHealth Group raised its full-year guidance and is rebounding from a disastrous 2025.
Got $5,000? These Are 3 of the Cheapest Growth Stocks to Buy Right Now
04:21am, Sunday, 09'th Nov 2025
The stocks listed here trade at forward price-to-earnings multiples of less than 20. They have underrated growth prospects, which could set them up for better-than-expected gains in the long run.
Healthcare Q3 Dividend Roundup: I Prefer AbbVie Over Pfizer
06:38am, Saturday, 08'th Nov 2025
AbbVie's and Pfizer's Q3 earnings and dividend updates prompt a rating upgrade to Hold for ABBV and reiteration of Sell for PFE. PFE's higher yield (almost 7%) and single-digit P/E (FY1 P/E is ~8x onl
Investors Heavily Search AbbVie Inc. (ABBV): Here is What You Need to Know
10:01am, Wednesday, 05'th Nov 2025
Recently, Zacks.com users have been paying close attention to AbbVie (ABBV). This makes it worthwhile to examine what the stock has in store.
AbbVie (NYSE:ABBV) Stock Price Up 1.9% After Analyst Upgrade
02:42am, Wednesday, 05'th Nov 2025
AbbVie Inc. (NYSE: ABBV - Get Free Report)'s stock price was up 1.9% during mid-day trading on Tuesday after JPMorgan Chase and Co. raised their price target on the stock from $250.00 to $260.00. JPMo
Here Are Tuesday's Top Wall Street Analyst Research Calls: Apple, AbbVie, Broadcom, CyberArk, Palantir Technologies and More
08:11am, Tuesday, 04'th Nov 2025
The S&P 500 and NASDAQ futures are trading down over 1% on Tuesday, following Palantir's 6.9% decline despite beating earnings expectations and giving strong forward guidance.
2 Healthcare Stocks for Individual Investors With a 10-Year Time Horizon
05:15am, Tuesday, 04'th Nov 2025
Long-term investors shouldn't overlook this top pharma stock and top medical device maker. AbbVie is seeing impressive growth from both its immunology portfolio and neuroscience products.
Best Medical Stocks To Watch Today – November 2nd
03:05am, Tuesday, 04'th Nov 2025
Eli Lilly and Company, Pfizer, UnitedHealth Group, AbbVie, and Johnson and Johnson are the five Medical stocks to watch today, according to MarketBeat's stock screener tool. "Medical stocks" are share
